<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Creatine Safety: The Complete Evidence-Based Guide</title>
  <meta name="description" content="The most comprehensive evidence-based guide to creatine safety. Covers kidneys, liver, heart, hair, dehydration, pregnancy, drug interactions, and long-term...">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://creatinepedia.com/safety/creatine-safety-complete-guide">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://creatinepedia.com/safety/creatine-safety-complete-guide">
  <meta property="og:title" content="Creatine Safety: The Complete Evidence-Based Guide">
  <meta property="og:description" content="The most comprehensive evidence-based guide to creatine safety. Covers kidneys, liver, heart, hair, dehydration, pregnancy, drug interactions, and long-term...">
  <meta property="og:site_name" content="Creatinepedia">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Creatine Safety: The Complete Evidence-Based Guide">
  <meta name="twitter:description" content="The most comprehensive evidence-based guide to creatine safety. Covers kidneys, liver, heart, hair, dehydration, pregnancy, drug interactions, and long-term...">
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect fill='%230f172a' width='100' height='100' rx='12'/><text x='50' y='68' font-family='monospace' font-size='40' fill='%230284c7' text-anchor='middle'>Cr</text></svg>">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <script src="https://cdn.tailwindcss.com"></script>
  <script>
    tailwind.config = {
      darkMode: 'class',
      theme: {
        extend: {
          fontFamily: {
            sans: ['DM Sans', 'system-ui', 'sans-serif'],
            serif: ['Instrument Serif', 'Georgia', 'serif'],
          },
          colors: {
            slate: { 925: '#0c0f14', 950: '#090b10' }
          }
        }
      }
    }
  </script>
  <style>
    ::selection { background: rgba(2, 132, 199, 0.3); }
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: var(--bg-secondary, #18181b); }
    ::-webkit-scrollbar-thumb { background: var(--border, #27272a); border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #3f3f46; }

    /* Article body — light mode */
    .article-body { max-width: 720px; margin: 0 auto; padding: 0 1rem; }
    .article-body h1 { font-family: 'Instrument Serif', Georgia, serif; font-size: 2.75rem; line-height: 1.15; margin-bottom: 1rem; color: #0f172a; }
    .article-body h2 { font-family: 'Instrument Serif', Georgia, serif; font-size: 1.875rem; margin: 2.5rem 0 1rem; color: #0f172a; }
    .article-body h3 { font-size: 1.25rem; font-weight: 600; margin: 2rem 0 0.75rem; color: #0f172a; }
    .article-body p { margin-bottom: 1.5rem; color: #475569; line-height: 1.8; }
    .article-body a { color: #0284c7; text-decoration: none; }
    .article-body a:hover { text-decoration: underline; }
    .article-body ul, .article-body ol { margin: 1.5rem 0; padding-left: 1.5rem; color: #475569; }
    .article-body li { margin-bottom: 0.75rem; line-height: 1.7; }
    .article-body strong { color: #1e293b; }
    .article-body blockquote { border-left: 3px solid #0284c7; padding-left: 1.5rem; margin: 2rem 0; font-style: italic; color: #334155; }
    .article-body .meta { color: #64748b; font-size: 0.9rem; margin-bottom: 2rem; }
    .article-body table { width: 100%; border-collapse: collapse; margin: 2rem 0; }
    .article-body th, .article-body td { text-align: left; padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; color: #475569; }
    .article-body th { color: #0f172a; font-weight: 600; border-bottom: 2px solid #cbd5e1; }
    .article-body .cta-box {
      background: linear-gradient(135deg, rgba(2, 132, 199, 0.08), rgba(13, 148, 136, 0.04));
      border: 1px solid rgba(2, 132, 199, 0.2);
      border-radius: 16px; padding: 2.5rem; margin: 3rem 0; text-align: center;
    }
    .article-body .cta-box h3 { margin-top: 0; font-family: 'Instrument Serif', Georgia, serif; font-size: 1.5rem; }
    .article-body .cta-box p { color: #64748b; margin-bottom: 1.5rem; }
    .article-body .cta-button {
      display: inline-block; background: #0284c7; color: #ffffff;
      padding: 1rem 2rem; border-radius: 8px; font-weight: 600;
      text-decoration: none; transition: background 0.2s;
    }
    .article-body .cta-button:hover { background: #0ea5e9; text-decoration: none; }
    .article-body .related-articles { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .related-articles h3 { margin-bottom: 1rem; }
    .article-body .related-articles ul { list-style: none; padding: 0; }
    .article-body .related-articles li { margin-bottom: 0.5rem; }
    .article-body .faq-section { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .faq-section > h2 { margin-top: 0; }
    .article-body .faq-item { margin-bottom: 2rem; }
    .article-body .faq-item h3 { color: #0f172a; margin-bottom: 0.5rem; }
    .article-body .faq-item p { margin-bottom: 0; }

    /* Article body — dark mode */
    .dark .article-body h1, .dark .article-body h2, .dark .article-body h3 { color: #fafaf9; }
    .dark .article-body p { color: #a1a1aa; }
    .dark .article-body ul, .dark .article-body ol { color: #a1a1aa; }
    .dark .article-body strong { color: #e4e4e7; }
    .dark .article-body a { color: #38bdf8; }
    .dark .article-body blockquote { color: #d4d4d8; }
    .dark .article-body .meta { color: #71717a; }
    .dark .article-body th, .dark .article-body td { border-bottom-color: #27272a; color: #a1a1aa; }
    .dark .article-body th { color: #fafaf9; border-bottom-color: #3f3f46; }
    .dark .article-body .cta-box { background: linear-gradient(135deg, rgba(2, 132, 199, 0.12), rgba(13, 148, 136, 0.06)); }
    .dark .article-body .cta-box p { color: #a1a1aa; }
    .dark .article-body .related-articles { border-top-color: #27272a; }
    .dark .article-body .faq-section { border-top-color: #27272a; }
    .dark .article-body .faq-item h3 { color: #fafaf9; }

    /* Newsletter section */
    #newsletter input::placeholder { color: #94a3b8; }
    .dark #newsletter input::placeholder { color: #52525b; }


    /* Mega menu */
    .mega-panel { transition: opacity 0.15s ease, visibility 0.15s ease; }
    .mega-panel.hidden { opacity: 0; visibility: hidden; display: none; }
    .mega-panel:not(.hidden) { opacity: 1; visibility: visible; display: block; }
    .mega-link {
      display: block; padding: 6px 0;
      font-size: 0.875rem; color: #475569;
      transition: color 0.15s;
    }
    .mega-link:hover { color: #0f172a; text-decoration: none; }
    .dark .mega-link { color: #a1a1aa; }
    .dark .mega-link:hover { color: #fafaf9; }
    .mega-view-all {
      display: inline-block; margin-top: 12px;
      font-size: 0.8125rem; font-weight: 500;
      color: #0284c7; transition: color 0.15s;
    }
    .mega-view-all:hover { color: #0ea5e9; text-decoration: none; }
    .dark .mega-view-all { color: #38bdf8; }
    .dark .mega-view-all:hover { color: #7dd3fc; }

    /* Nav effects */
    .nav-link { position: relative; }
    .nav-link::after {
      content: ''; position: absolute; bottom: -2px; left: 0;
      width: 0; height: 1px; background: #0284c7; transition: width 0.3s ease;
    }
    .nav-link:hover::after { width: 100%; }
    .cta-glow { position: relative; }
    .cta-glow::before {
      content: ''; position: absolute; inset: -2px;
      background: linear-gradient(135deg, #0284c7, #0891b2);
      border-radius: inherit; opacity: 0; filter: blur(12px);
      transition: opacity 0.3s ease; z-index: -1;
    }
    .cta-glow:hover::before { opacity: 0.4; }

    /* Active trigger state */
    .mega-trigger[aria-expanded="true"] { color: #0f172a; }
    .dark .mega-trigger[aria-expanded="true"] { color: #fafaf9; }
    .mega-trigger[aria-expanded="true"] svg { transform: rotate(180deg); }


    @media (max-width: 768px) {
      .article-body h1 { font-size: 2rem; }
      .article-body h2 { font-size: 1.5rem; }
    }
  </style>
  <script type="application/ld+json">
  {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What Creatine Is and How It Works?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Creatine is a naturally occurring amino acid derivative synthesized in the human body from arginine, glycine, and methionine. The liver, kidneys, and pancreas produce approximately 1-2 grams per day. An additional 1-2 grams per day comes from dietary sources, primarily meat and fish. The body stores approximately 120-140 grams of creatine, with 95% residing in skeletal muscle as free creatine and phosphocreatine."
      }
    },
    {
      "@type": "Question",
      "name": "Is kidney safety safe?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The most widespread safety concern is kidney damage. The evidence conclusively refutes this claim in healthy individuals."
      }
    },
    {
      "@type": "Question",
      "name": "Is liver safety safe?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Liver function markers (ALT, AST, GGT, ALP, bilirubin) have been measured in numerous creatine trials spanning weeks to years. No study has found evidence of hepatotoxicity. Kreider et al. (2003) tracked liver enzymes across 21 months without detecting abnormalities. Schilling et al. (2001) found no differences between long-term creatine users and non-users."
      }
    },
    {
      "@type": "Question",
      "name": "Is cardiovascular safety safe?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Blood pressure, lipid profiles, and cardiac function markers are either unaffected or mildly improved by creatine supplementation. Earnest et al. (1996) found reductions in total cholesterol and triglycerides. Steenge et al. (2001) demonstrated that creatine supplementation reduced plasma homocysteine, an independent cardiovascular risk factor. No study has found elevated blood pressure, arrhythmias, or other cardiovascular adverse effects."
      }
    },
    {
      "@type": "Question",
      "name": "Is hair loss safe?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The hair loss myth originates from a single study. Van der Merwe et al. (2009) found elevated DHT (within normal physiological ranges) in 20 rugby players during creatine loading. No hair loss was measured, observed, or reported. No subsequent study has replicated the DHT finding. A 2021 meta-analysis by Antonio et al. of 22 studies found no effect of creatine on testosterone, free testosterone, or DHT."
      }
    }
  ]
}
  </script>
</head>
<body class="bg-slate-50 dark:bg-slate-950 font-sans antialiased">

  <nav class="fixed top-0 left-0 right-0 z-50 border-b border-slate-200 dark:border-zinc-800/60 bg-white/90 dark:bg-slate-950/90 backdrop-blur-md">
    <div class="max-w-7xl mx-auto">
      <div class="flex items-center justify-between h-16 px-6">
        <!-- Logo -->
        <a href="/" class="flex items-center gap-3 group">
          <div class="w-8 h-8 rounded-md bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center group-hover:border-sky-500/50 transition-colors">
            <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
          </div>
          <span class="text-slate-500 dark:text-zinc-400 text-sm tracking-tight">
            <span class="text-slate-800 dark:text-zinc-200 font-medium">Creatine</span><span class="text-sky-600 dark:text-sky-400">pedia</span>
          </span>
        </a>

        <!-- Desktop Nav -->
        <div class="hidden lg:flex items-center gap-1">

          <!-- Science dropdown -->
          <div class="relative" data-mega="science">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Research
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- Applications dropdown -->
          <div class="relative" data-mega="applications">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Applications
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- All Articles link -->
          <a href="/articles" class="nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors">All Articles</a>

          <div class="w-px h-4 bg-slate-300 dark:bg-zinc-800 mx-2"></div>

          <!-- CTA -->
          <a href="#newsletter" class="px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors cta-glow">New Entries</a>
        </div>

        <!-- Mobile menu button -->
        <button id="mobile-menu-btn" class="lg:hidden p-2 text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200">
          <svg id="menu-icon" class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
          <svg id="close-icon" class="w-5 h-5 hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"></path></svg>
        </button>
      </div>

      <!-- ═══ MEGA PANEL: Research ═══ -->
      <div id="mega-science" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-3 gap-8">
            <!-- Column 1: Science -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Science & Mechanisms</span>
              </div>
              <div class="space-y-1">
                <a href="/science/what-is-creatine-monohydrate" class="mega-link">What Is Creatine Monohydrate?</a>
                <a href="/science/how-creatine-works-in-the-body" class="mega-link">How Creatine Works</a>
                <a href="/science/creatine-atp-resynthesis" class="mega-link">ATP Resynthesis</a>
                <a href="/science/creatine-and-muscle-growth" class="mega-link">Muscle Growth Research</a>
                <a href="/science/creatine-and-brain-function" class="mega-link">Brain Function</a>
                <a href="/science/creatine-and-aging" class="mega-link">Aging & Sarcopenia</a>
              </div>
              <a href="/science" class="mega-view-all">All 20 articles &rarr;</a>
            </div>

            <!-- Column 2: Dosing & Safety -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-teal-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Dosing & Safety</span>
              </div>
              <div class="space-y-1">
                <a href="/dosing/creatine-loading-protocol" class="mega-link">Loading Protocol</a>
                <a href="/dosing/creatine-maintenance-dose" class="mega-link">Maintenance Dosing</a>
                <a href="/dosing/creatine-timing-before-or-after-workout" class="mega-link">Timing: Before or After?</a>
                <a href="/safety/is-creatine-safe" class="mega-link">Is Creatine Safe?</a>
                <a href="/safety/creatine-and-kidneys" class="mega-link">Kidney Health</a>
                <a href="/safety/creatine-and-hair-loss" class="mega-link">Hair Loss Myth</a>
              </div>
              <a href="/dosing" class="mega-view-all">Dosing (15) &rarr;</a>
              <span class="mx-2 text-slate-300 dark:text-zinc-700">|</span>
              <a href="/safety" class="mega-view-all">Safety (15) &rarr;</a>
            </div>

            <!-- Column 3: CTA Card -->
            <div class="bg-gradient-to-br from-sky-500/10 to-teal-500/5 dark:from-sky-500/15 dark:to-teal-500/5 border border-sky-500/20 rounded-xl p-6 flex flex-col justify-between">
              <div>
                <h3 class="text-lg font-semibold text-slate-900 dark:text-zinc-100 mb-2">The Creatine Encyclopedia</h3>
                <p class="text-sm text-slate-600 dark:text-zinc-400 mb-4">100 entries. Every claim cited from peer-reviewed sources. No marketing. No supplement sales.</p>
              </div>
              <a href="/science/creatine-mechanisms-summary" class="inline-flex items-center justify-center px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg text-sm transition-colors cta-glow">
                Start Reading
              </a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ MEGA PANEL: Applications ═══ -->
      <div id="mega-applications" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-4 gap-8">
            <!-- Column 1: By Sport -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-amber-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">By Sport</span>
              </div>
              <div class="space-y-1">
                <a href="/sports/creatine-for-powerlifting" class="mega-link">Powerlifting</a>
                <a href="/sports/creatine-for-bodybuilding" class="mega-link">Bodybuilding</a>
                <a href="/sports/creatine-for-crossfit" class="mega-link">CrossFit</a>
                <a href="/sports/creatine-for-mma" class="mega-link">MMA & Combat Sports</a>
                <a href="/sports/creatine-for-soccer" class="mega-link">Soccer</a>
                <a href="/sports/creatine-for-swimming" class="mega-link">Swimming</a>
              </div>
              <a href="/sports" class="mega-view-all">All 20 sports &rarr;</a>
            </div>

            <!-- Column 2: Comparisons -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-violet-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">vs Other Supplements</span>
              </div>
              <div class="space-y-1">
                <a href="/comparisons/creatine-vs-protein-powder" class="mega-link">vs Protein Powder</a>
                <a href="/comparisons/creatine-vs-bcaa" class="mega-link">vs BCAAs</a>
                <a href="/comparisons/creatine-vs-beta-alanine" class="mega-link">vs Beta-Alanine</a>
                <a href="/comparisons/creatine-vs-pre-workout" class="mega-link">vs Pre-Workout</a>
                <a href="/comparisons/creatine-vs-ashwagandha" class="mega-link">vs Ashwagandha</a>
              </div>
              <a href="/comparisons" class="mega-view-all">All 15 comparisons &rarr;</a>
            </div>

            <!-- Column 3: Product Quality -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-emerald-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Product Quality</span>
              </div>
              <div class="space-y-1">
                <a href="/quality/creatine-monohydrate-vs-hcl" class="mega-link">Monohydrate vs HCl</a>
                <a href="/quality/creatine-forms-comparison" class="mega-link">All Forms Compared</a>
                <a href="/quality/third-party-testing-creatine" class="mega-link">Third-Party Testing</a>
                <a href="/quality/creapure-vs-generic-creatine" class="mega-link">Creapure vs Generic</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/quality" class="mega-view-all">All 15 guides &rarr;</a>
            </div>

            <!-- Column 4: Quick Links -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Quick Links</span>
              </div>
              <div class="space-y-1">
                <a href="/science/creatine-mechanisms-summary" class="mega-link">Complete Science Guide</a>
                <a href="/dosing/creatine-dosing-protocols-summary" class="mega-link">Complete Dosing Guide</a>
                <a href="/safety/creatine-safety-complete-guide" class="mega-link">Complete Safety Guide</a>
                <a href="/sports/creatine-for-sport-summary" class="mega-link">Every Sport Guide</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/articles" class="mega-view-all">All 100 articles &rarr;</a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ Mobile Menu ═══ -->
      <div id="mobile-menu" class="hidden lg:hidden border-t border-slate-200 dark:border-zinc-800 bg-white dark:bg-slate-950 max-h-[80vh] overflow-y-auto">
        <div class="px-6 py-4 space-y-1">
          <!-- Research -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Research
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Science</p>
            <a href="/science/what-is-creatine-monohydrate" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">What Is Creatine?</a>
            <a href="/science/how-creatine-works-in-the-body" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">How Creatine Works</a>
            <a href="/science" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Dosing</p>
            <a href="/dosing/creatine-loading-protocol" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Loading Protocol</a>
            <a href="/dosing/creatine-maintenance-dose" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Maintenance Dose</a>
            <a href="/dosing" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Safety</p>
            <a href="/safety/is-creatine-safe" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Is Creatine Safe?</a>
            <a href="/safety/creatine-and-kidneys" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Kidney Health</a>
            <a href="/safety" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
          </div>

          <!-- Applications -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Applications
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Sports</p>
            <a href="/sports/creatine-for-powerlifting" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Powerlifting</a>
            <a href="/sports/creatine-for-bodybuilding" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Bodybuilding</a>
            <a href="/sports" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 sports &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Comparisons</p>
            <a href="/comparisons/creatine-vs-protein-powder" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs Protein Powder</a>
            <a href="/comparisons/creatine-vs-bcaa" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs BCAAs</a>
            <a href="/comparisons" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 comparisons &rarr;</a>
          </div>

          <!-- Direct links -->
          <a href="/articles" class="block py-3 text-slate-800 dark:text-zinc-200 font-medium">All Articles</a>

          <!-- CTA -->
          <a href="#newsletter" class="block mt-4 py-3 bg-sky-600 text-white text-center font-semibold rounded-lg">Get New Entries</a>
        </div>
      </div>
    </div>
  </nav>

  <main class="pt-24 pb-16">
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mb-6">
      <div class="flex items-center gap-2 text-sm">
        <a href="/" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Home</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/articles" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Articles</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/safety" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Safety & Concerns</a>
      </div>
    </div>
    <div class="article-body">
      <article>
    <h1>Creatine Safety: The Complete Evidence-Based Guide</h1>

    <p>This is the most comprehensive safety resource on this site. It synthesizes the evidence reviewed across all dedicated safety articles into a single reference, covering every major concern, every population studied, and every organ system examined. If you read one article about creatine safety, make it this one.</p>

    <p>Creatine monohydrate has been commercially available since the early 1990s and has been the subject of over 500 peer-reviewed studies. It is the most researched sports supplement in history. The International Society of Sports Nutrition (ISSN), the American College of Sports Medicine, and the European Food Safety Authority have all evaluated its safety. Their conclusion is consistent: creatine monohydrate at recommended doses is safe for healthy individuals.</p>

    <h2>What Creatine Is and How It Works</h2>

    <p>Creatine is a naturally occurring amino acid derivative synthesized in the human body from arginine, glycine, and methionine. The liver, kidneys, and pancreas produce approximately 1-2 grams per day. An additional 1-2 grams per day comes from dietary sources, primarily meat and fish. The body stores approximately 120-140 grams of creatine, with 95% residing in skeletal muscle as free creatine and phosphocreatine.</p>

    <p>Phosphocreatine serves as a rapid energy buffer. When ATP (the cell's energy currency) is depleted during high-intensity activity, the enzyme creatine kinase transfers a phosphate group from phosphocreatine to ADP, regenerating ATP within seconds. Supplementation increases intramuscular creatine and phosphocreatine stores to their saturation point (approximately 160 mmol/kg dry muscle), enhancing this energy buffering capacity.</p>

    <p>This mechanism is entirely distinct from how anabolic steroids, stimulants, or other performance-enhancing substances work. Creatine does not bind hormone receptors, does not stimulate the nervous system, and does not alter endocrine function.</p>

    <h2>Kidney Safety</h2>

    <p>The most widespread safety concern is kidney damage. The evidence conclusively refutes this claim in healthy individuals.</p>

    <p>Poortmans and Francaux (1999) measured glomerular filtration rate (GFR) directly in creatine users and found no impairment. Lugaresi et al. (2013) used cystatin C, a kidney marker unaffected by creatine intake, and confirmed normal renal function after 12 weeks at 10 g/day. Gualano et al. (2008) even studied creatine supplementation in a person with a single kidney and found no adverse effects. Kreider et al. (2003) tracked kidney markers across 21 months of continuous supplementation with no abnormalities.</p>

    <p>The confusion arises because creatine is metabolized to creatinine, a standard marker used to estimate kidney function. Supplementation increases creatinine production, which elevates serum creatinine on blood tests. This creates the appearance of reduced kidney function when the kidneys are actually working normally. Cystatin C testing resolves this artifact.</p>

    <p><strong>Caveat:</strong> Individuals with pre-existing kidney disease should consult a nephrologist before supplementing. The safety data applies to healthy kidneys.</p>

    <p><em>Detailed article: <a href="/safety/creatine-and-kidneys">Creatine and Kidney Health</a></em></p>

    <h2>Liver Safety</h2>

    <p>Liver function markers (ALT, AST, GGT, ALP, bilirubin) have been measured in numerous creatine trials spanning weeks to years. No study has found evidence of hepatotoxicity. Kreider et al. (2003) tracked liver enzymes across 21 months without detecting abnormalities. Schilling et al. (2001) found no differences between long-term creatine users and non-users.</p>

    <p>Interestingly, exogenous creatine supplementation may reduce the liver's biosynthetic workload. The liver normally synthesizes creatine via the GAMT enzyme. When dietary creatine is adequate, endogenous synthesis downregulates, potentially reducing hepatic metabolic demand.</p>

    <p><em>Detailed article: <a href="/safety/creatine-and-liver">Creatine and Liver Function</a></em></p>

    <h2>Cardiovascular Safety</h2>

    <p>Blood pressure, lipid profiles, and cardiac function markers are either unaffected or mildly improved by creatine supplementation. Earnest et al. (1996) found reductions in total cholesterol and triglycerides. Steenge et al. (2001) demonstrated that creatine supplementation reduced plasma homocysteine, an independent cardiovascular risk factor. No study has found elevated blood pressure, arrhythmias, or other cardiovascular adverse effects.</p>

    <p>The heart itself relies heavily on the phosphocreatine energy shuttle. Cardiac creatine depletion is a hallmark of heart failure (Neubauer et al., 1997). Gordon et al. (1995) found that creatine supplementation improved ejection fraction in heart failure patients, positioning creatine as a potential therapeutic agent rather than a cardiovascular risk.</p>

    <p><em>Detailed article: <a href="/safety/creatine-and-heart-health">Creatine and Heart Health</a></em></p>

    <h2>Hair Loss</h2>

    <p>The hair loss myth originates from a single study. Van der Merwe et al. (2009) found elevated DHT (within normal physiological ranges) in 20 rugby players during creatine loading. No hair loss was measured, observed, or reported. No subsequent study has replicated the DHT finding. A 2021 meta-analysis by Antonio et al. of 22 studies found no effect of creatine on testosterone, free testosterone, or DHT.</p>

    <p>The logical chain (creatine raises DHT, DHT causes hair loss, therefore creatine causes hair loss) fails at every link: the DHT elevation has not been replicated, circulating DHT is a poor predictor of individual hair loss, and no hair loss has ever been documented from creatine use.</p>

    <p><em>Detailed article: <a href="/safety/creatine-and-hair-loss">Creatine and Hair Loss</a></em></p>

    <h2>Dehydration and Cramping</h2>

    <p>Creatine does not cause dehydration. Lopez et al. (2009) conducted a systematic review confirming no adverse effects on hydration status or exercise heat tolerance. Powers et al. (2003) demonstrated that creatine increases total body water without depleting extracellular fluid. The body has more water available during creatine supplementation, not less.</p>

    <p>Creatine does not cause muscle cramps. Greenwood et al. (2003) found that creatine-supplementing football players experienced fewer cramps, heat illnesses, and injuries than non-supplementing players. The ISSN position stand notes that the preponderance of evidence suggests creatine may reduce rather than increase cramping incidence.</p>

    <p><em>Detailed articles: <a href="/safety/creatine-and-dehydration">Creatine and Dehydration</a> | <a href="/safety/creatine-and-cramping">Creatine and Muscle Cramps</a></em></p>

    <h2>Bloating and Gastrointestinal Issues</h2>

    <p>Creatine-related "bloating" encompasses two distinct phenomena. Intracellular water retention (1-3 kg during loading) is normal, expected, and potentially anabolic. It occurs inside muscle cells, not subcutaneously. Gastrointestinal discomfort (stomach cramping, nausea, diarrhea) is dose-dependent and occurs primarily with large single doses on an empty stomach. It is resolved by dividing doses, taking creatine with food, and ensuring adequate fluid intake.</p>

    <p><em>Detailed article: <a href="/safety/creatine-and-bloating">Creatine and Bloating</a></em></p>

    <h2>Blood Sugar and Diabetes</h2>

    <p>Creatine does not worsen blood sugar control. Research in type 2 diabetic patients suggests it may improve glycemic management. Gualano et al. (2011) found that creatine combined with exercise training improved HbA1c and glucose tolerance more than exercise alone. The mechanism involves enhanced GLUT-4 glucose transporter expression in skeletal muscle (Op 't Eijnde et al., 2001). Kidney function was preserved in diabetic populations studied.</p>

    <p><em>Detailed article: <a href="/safety/creatine-and-diabetes">Creatine and Blood Sugar</a></em></p>

    <h2>Long-Term Safety</h2>

    <p>Multi-year controlled studies provide the strongest safety evidence. Schilling et al. (2001) found no health marker abnormalities in athletes supplementing for up to four years. Kreider et al. (2003) tracked 69 health markers across 21 months without detecting adverse trends. Three decades of commercial availability involving millions of users have not generated pharmacovigilance signals suggesting long-term harm.</p>

    <p><em>Detailed article: <a href="/safety/creatine-long-term-safety">Creatine Long-Term Safety</a></em></p>

    <h2>Drug Interactions</h2>

    <p>No clinically significant pharmacological interaction between creatine and any common medication has been documented. The primary interaction is diagnostic: elevated serum creatinine can confound kidney function estimates used for dosing renally-cleared medications. Theoretical caution applies when combining creatine with nephrotoxic drugs, diuretics, or hypoglycemic agents, based on the precautionary principle rather than documented adverse events. Disclosure of creatine use to healthcare providers is essential.</p>

    <p><em>Detailed article: <a href="/safety/creatine-drug-interactions">Creatine and Medication Interactions</a></em></p>

    <h2>Creatinine and Lab Work</h2>

    <p>Creatine supplementation raises serum creatinine because creatinine is a direct metabolic byproduct of creatine. Standard eGFR equations interpret this elevation as reduced kidney function, creating a false-positive result. Cystatin C-based eGFR provides accurate kidney function assessment unaffected by creatine intake. Creatine users should disclose supplementation before blood work and request cystatin C testing if kidney function flags are raised.</p>

    <p><em>Detailed article: <a href="/safety/creatine-and-creatinine-levels">Creatine and Creatinine Levels</a></em></p>

    <h2>Pregnancy and Breastfeeding</h2>

    <p>This is the one area of genuine uncertainty. Animal studies suggest maternal creatine supplementation may protect the fetal brain during birth-related oxygen deprivation (Dickinson et al., 2014; Ellery et al., 2016). Human clinical trial data is insufficient to recommend for or against supplementation during pregnancy. Creatine is naturally present in breast milk. Pregnant and breastfeeding women should consult their obstetrician before supplementing.</p>

    <p><em>Detailed article: <a href="/safety/creatine-during-pregnancy">Creatine During Pregnancy</a></em></p>

    <h2>Populations Studied</h2>

    <p>The safety evidence encompasses a remarkably broad range of populations:</p>

    <p><strong>Athletes</strong> (hundreds of studies, multiple sports, both sexes, recreational through elite). <strong>Older adults</strong> (55-80+, including sarcopenia and cognitive decline research). <strong>Children and adolescents</strong> (primarily clinical contexts, muscular dystrophies, TBI). <strong>Clinical patients</strong> (Parkinson's disease, Huntington's disease, ALS, muscular dystrophies, type 2 diabetes, depression, traumatic brain injury). <strong>Special populations</strong> (single kidney, vegetarians, military personnel).</p>

    <p>The breadth of populations studied without adverse findings strengthens the safety case considerably. If creatine produced organ damage, the signal would have appeared in at least one of these populations.</p>

    <h2>What the ISSN Position Stand Says</h2>

    <p>The International Society of Sports Nutrition position stand on creatine (Kreider et al., 2017) represents the most authoritative consensus statement on creatine safety. Key conclusions include:</p>

    <p>Creatine monohydrate is the most effective ergogenic nutritional supplement currently available for increasing high-intensity exercise capacity and lean body mass. There is no scientific evidence that short- or long-term use of creatine monohydrate has any detrimental effects on otherwise healthy individuals when used at established guidelines. The only consistently reported side effect is weight gain from water retention. Creatine monohydrate is the most extensively studied and clinically effective form of creatine. Claims that different forms of creatine are safer or more effective than monohydrate are not supported by peer-reviewed evidence.</p>

    <h2>Recommended Dosing for Safety and Efficacy</h2>

    <p>The doses validated for both safety and efficacy are as follows:</p>

    <p><strong>Loading (optional):</strong> 20 g/day divided into four 5 g doses for 5-7 days. Saturates muscle stores rapidly. Associated with more GI symptoms and greater initial water retention. Not required for achieving saturation.</p>

    <p><strong>Maintenance:</strong> 3-5 g/day continuously. Achieves full saturation within 3-4 weeks without loading. This is the dose used in the majority of long-term safety studies.</p>

    <p><strong>No cycling required.</strong> Continuous daily supplementation maintains muscle creatine stores at saturation. There is no tolerance effect and no safety-based reason to cycle.</p>

    <h2>Who Should Consult a Physician First</h2>

    <p>While creatine is safe for the general healthy population, the following groups should discuss supplementation with their healthcare provider: individuals with pre-existing kidney disease, individuals with pre-existing liver disease, pregnant or breastfeeding women, individuals taking nephrotoxic medications, individuals taking medications with narrow therapeutic windows that are renally dosed, and children under medical care for chronic conditions.</p>

    <p>These recommendations reflect the standard of care for any dietary intervention in medically complex populations, not evidence of harm from creatine specifically.</p>

    <h2>Frequently Asked Questions</h2>

    <h3>Is creatine safe to take every day?</h3>
    <p>Yes. Creatine monohydrate at 3-5 grams per day has been studied continuously for up to 5 years with no adverse effects on kidney function, liver function, lipid profiles, blood glucose, or any other measured health marker. The ISSN position stand confirms daily supplementation is safe for healthy individuals.</p>

    <h3>Does creatine damage your kidneys?</h3>
    <p>No. Multiple controlled studies measuring actual kidney function (GFR, cystatin C, albumin excretion) have found no impairment in creatine users. Elevated serum creatinine in creatine users reflects increased creatinine production, not decreased kidney function. The ISSN confirms no evidence of renal dysfunction in healthy individuals.</p>

    <h3>Does creatine cause hair loss?</h3>
    <p>No study has measured or reported hair loss from creatine supplementation. The myth originates from a single 2009 study that found elevated DHT levels (within normal ranges) in 20 rugby players. This finding has never been replicated. A 2021 meta-analysis of 22 studies found no effect of creatine on testosterone or DHT.</p>

    <h3>Does creatine cause dehydration?</h3>
    <p>No. A systematic review by Lopez et al. (2009) found no evidence that creatine impairs hydration status or exercise heat tolerance. Creatine increases total body water, meaning the body has more water available, not less. Multiple studies in hot environments confirm no dehydration risk.</p>

    <h3>Is creatine a steroid?</h3>
    <p>No. Creatine is a naturally occurring amino acid derivative made from arginine, glycine, and methionine. It is produced by the liver, kidneys, and pancreas and obtained from dietary sources like meat and fish. It does not bind to androgen receptors, does not alter testosterone, and is not banned by any sports organization including WADA.</p>

    <h3>Can women take creatine?</h3>
    <p>Yes. Creatine works through the same energy system in both sexes. Research in female populations shows benefits for exercise performance, body composition, and potentially bone health. The 1-2 kg of intracellular water retention does not produce a bulky appearance.</p>

    <h3>Should I cycle creatine?</h3>
    <p>No. Creatine does not produce tolerance, and the phosphocreatine system does not downregulate with continued use. Muscle stores reach a saturation point and are maintained with daily supplementation. Long-term studies show continued safety without cycling. The ISSN recommends continuous daily use.</p>

    <h3>Can creatine raise my blood pressure?</h3>
    <p>No consistent evidence supports this concern. Multiple studies measuring blood pressure before and after creatine supplementation, including during loading phases, have found no significant elevation in normotensive individuals. The ISSN position stand confirms no adverse cardiovascular effects.</p>

    <h3>Is creatine safe during pregnancy?</h3>
    <p>This is currently uncertain. Animal studies suggest maternal creatine may protect the fetal brain during birth complications, but human clinical trial data is insufficient to recommend supplementation during pregnancy. Pregnant women should consult their obstetrician before taking creatine.</p>

    <h3>Why does creatine raise my creatinine levels?</h3>
    <p>Creatine is naturally converted to creatinine at a rate of about 1.7% per day. Supplementation increases your creatine pool, which increases creatinine production. This raises serum creatinine on blood tests without any change in kidney function. Ask your doctor for a cystatin C test for an accurate kidney function assessment.</p>

    <section>
      <h2>Bibliography</h2>
      <ol>
        <li>Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. <em>J Int Soc Sports Nutr</em>. 2017;14:18. doi:10.1186/s12970-017-0173-z</li>
        <li>Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. <em>Med Sci Sports Exerc</em>. 1999;31(8):1108-1110. doi:10.1097/00005768-199908000-00005</li>
        <li>Lugaresi R, Leme M, de Salles Painelli V, et al. Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet? <em>J Int Soc Sports Nutr</em>. 2013;10(1):26. doi:10.1186/1550-2783-10-26</li>
        <li>Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. <em>Pharmacol Rev</em>. 2001;53(2):161-176. PMID: 11356982</li>
        <li>Kreider RB, Melton C, Rasmussen CJ, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. <em>Mol Cell Biochem</em>. 2003;244(1-2):95-104. doi:10.1023/A:1022469320296</li>
        <li>Schilling BK, Stone MH, Utter A, et al. Creatine supplementation and health variables: a retrospective study. <em>Med Sci Sports Exerc</em>. 2001;33(2):183-188. doi:10.1097/00005768-200102000-00002</li>
        <li>van der Merwe J, Brooks NE, Myburgh KH. Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. <em>Clin J Sport Med</em>. 2009;19(5):399-404. doi:10.1097/JSM.0b013e3181b8b52f</li>
        <li>Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? <em>J Int Soc Sports Nutr</em>. 2021;18(1):13. doi:10.1186/s12970-021-00412-w</li>
        <li>Lopez RM, Casa DJ, McDermott BP, et al. Does creatine supplementation hinder exercise heat tolerance or hydration status? A systematic review with meta-analyses. <em>J Athl Train</em>. 2009;44(2):215-223. doi:10.4085/1062-6050-44.2.215</li>
        <li>Greenwood M, Kreider RB, Greenwood L, Byars A. Cramping and injury incidence in collegiate football players are reduced by creatine supplementation. <em>J Athl Train</em>. 2003;38(3):216-219. PMID: 14608430</li>
        <li>Powers ME, Arnold BL, Weltman AL, et al. Creatine supplementation increases total body water without altering fluid distribution. <em>J Athl Train</em>. 2003;38(1):44-50. PMID: 12937471</li>
        <li>Dalbo VJ, Roberts MD, Stout JR, Kerksick CM. Putting to rest the myth of creatine supplementation leading to muscle cramps and dehydration. <em>Br J Sports Med</em>. 2008;42(7):567-573. doi:10.1136/bjsm.2007.042473</li>
        <li>Gualano B, de Salles Painelli V, Roschel H, et al. Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. <em>Med Sci Sports Exerc</em>. 2011;43(5):770-778. doi:10.1249/MSS.0b013e3181fcee7d</li>
        <li>Op 't Eijnde B, Urso B, Richter EA, Greenhaff PL, Hespel P. Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization. <em>Diabetes</em>. 2001;50(1):18-23. doi:10.2337/diabetes.50.1.18</li>
        <li>Earnest CP, Almada AL, Mitchell TL. High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women. <em>Clin Sci (Lond)</em>. 1996;91(1):113-118. doi:10.1042/cs0910113</li>
        <li>Steenge GR, Verhoef P, Greenhaff PL. The effect of creatine and resistance training on plasma homocysteine concentration in healthy volunteers. <em>Arch Intern Med</em>. 2001;161(11):1455-1456. doi:10.1001/archinte.161.11.1455</li>
        <li>Gordon A, Hultman E, Kaijser L, et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. <em>Cardiovasc Res</em>. 1995;30(3):413-418. doi:10.1016/S0008-6363(95)00069-0</li>
        <li>Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. <em>Circulation</em>. 1997;96(7):2190-2196. doi:10.1161/01.CIR.96.7.2190</li>
        <li>Dickinson H, Ellery S, Ireland Z, LaRosa D, Snow R, Walker DW. Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy. <em>BMC Pregnancy Childbirth</em>. 2014;14:150. doi:10.1186/1471-2393-14-150</li>
        <li>Gualano B, Ugrinowitsch C, Novaes RB, et al. Effects of creatine supplementation on renal function: a randomized, double-blind, placebo-controlled clinical trial. <em>Eur J Appl Physiol</em>. 2008;103(1):33-40. doi:10.1007/s00421-007-0669-3</li>
        <li>Mayhew DL, Mayhew JL, Ware JS. Effects of long-term creatine supplementation on liver and kidney functions in American college football players. <em>Int J Sport Nutr Exerc Metab</em>. 2002;12(4):453-460. doi:10.1123/ijsnem.12.4.453</li>
        <li>Smith-Ryan AE, Cabre HE, Eckerson JM, Candow DG. Creatine supplementation in women's health: a lifespan perspective. <em>Nutrients</em>. 2021;13(3):877. doi:10.3390/nu13030877</li>
        <li>Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. <em>Physiol Rev</em>. 2000;80(3):1107-1213. doi:10.1152/physrev.2000.80.3.1107</li>
      </ol>
    </section>
      
      
      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        
        <div class="faq-item">
          <h3>What Creatine Is and How It Works?</h3>
          <p>Creatine is a naturally occurring amino acid derivative synthesized in the human body from arginine, glycine, and methionine. The liver, kidneys, and pancreas produce approximately 1-2 grams per day. An additional 1-2 grams per day comes from dietary sources, primarily meat and fish. The body stores approximately 120-140 grams of creatine, with 95% residing in skeletal muscle as free creatine and phosphocreatine.</p>
        </div>
        <div class="faq-item">
          <h3>Is kidney safety safe?</h3>
          <p>The most widespread safety concern is kidney damage. The evidence conclusively refutes this claim in healthy individuals.</p>
        </div>
        <div class="faq-item">
          <h3>Is liver safety safe?</h3>
          <p>Liver function markers (ALT, AST, GGT, ALP, bilirubin) have been measured in numerous creatine trials spanning weeks to years. No study has found evidence of hepatotoxicity. Kreider et al. (2003) tracked liver enzymes across 21 months without detecting abnormalities. Schilling et al. (2001) found no differences between long-term creatine users and non-users.</p>
        </div>
        <div class="faq-item">
          <h3>Is cardiovascular safety safe?</h3>
          <p>Blood pressure, lipid profiles, and cardiac function markers are either unaffected or mildly improved by creatine supplementation. Earnest et al. (1996) found reductions in total cholesterol and triglycerides. Steenge et al. (2001) demonstrated that creatine supplementation reduced plasma homocysteine, an independent cardiovascular risk factor. No study has found elevated blood pressure, arrhythmias, or other cardiovascular adverse effects.</p>
        </div>
        <div class="faq-item">
          <h3>Is hair loss safe?</h3>
          <p>The hair loss myth originates from a single study. Van der Merwe et al. (2009) found elevated DHT (within normal physiological ranges) in 20 rugby players during creatine loading. No hair loss was measured, observed, or reported. No subsequent study has replicated the DHT finding. A 2021 meta-analysis by Antonio et al. of 22 studies found no effect of creatine on testosterone, free testosterone, or DHT.</p>
        </div>
      </section>
      </article>

      <!-- In-article CTA -->
      <div class="cta-box">
        <h3>Stay Current with Creatinepedia</h3>
        <p>Get notified when new entries are published. No hype, no marketing — just what the science shows.</p>
        <a href="#newsletter" class="cta-button">Get New Entries</a>
      </div>

      <!-- Pillar page link -->
      <div class="related-articles">
        <h3>Read the Full Guide</h3>
        <p style="margin-bottom: 0.75rem;"><a href="/safety/creatine-safety-complete-guide">Complete Safety Guide: Safety & Concerns</a> — comprehensive overview with all cited sources.</p>
      </div>
    </div>

    <!-- Category nav -->
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mt-12">
      <div class="flex items-center justify-between p-5 bg-slate-100 dark:bg-zinc-900/50 border border-slate-200 dark:border-zinc-800/60 rounded-xl">
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-1">Category</p>
          <a href="/safety" class="text-slate-800 dark:text-zinc-200 font-medium hover:text-sky-600 dark:hover:text-sky-400 transition-colors">Safety & Concerns</a>
        </div>
        <a href="/safety" class="text-sm text-sky-600 dark:text-sky-400 font-medium hover:underline">Browse all &rarr;</a>
      </div>
    </div>
  </main>

  <!-- Newsletter section -->
  <section id="newsletter" class="py-16 bg-slate-100 dark:bg-zinc-900/30 border-t border-slate-200 dark:border-zinc-800/60">
    <div class="max-w-xl mx-auto px-6 text-center">
      <h2 class="font-serif text-3xl text-slate-900 dark:text-zinc-100 mb-3">New Entries & Updates</h2>
      <p class="text-slate-600 dark:text-zinc-400 mb-6">New encyclopedia entries and updates — delivered when they matter. No spam. Unsubscribe anytime.</p>
      <form class="flex flex-col sm:flex-row gap-3 justify-center" onsubmit="return false;">
        <input type="email" placeholder="your@email.com" class="px-4 py-3 rounded-lg border border-slate-300 dark:border-zinc-700 bg-white dark:bg-zinc-800 text-slate-900 dark:text-zinc-100 focus:outline-none focus:ring-2 focus:ring-sky-500 w-full sm:w-72">
        <button type="submit" class="px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg transition-colors cta-glow">Subscribe</button>
      </form>
      <p class="text-xs text-slate-500 dark:text-zinc-600 mt-3">100% evidence-based. Every claim cited.</p>
    </div>
  </section>


  <footer class="py-16 border-t border-slate-200 dark:border-zinc-900">
    <div class="max-w-7xl mx-auto px-6">
      <div class="grid grid-cols-2 md:grid-cols-6 gap-8 mb-12">
        <div class="col-span-2 md:col-span-2">
          <div class="flex items-center gap-3 mb-3">
            <div class="w-8 h-8 rounded bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center">
              <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
            </div>
            <span class="text-slate-700 dark:text-zinc-300 font-medium">Creatinepedia</span>
          </div>
          <p class="text-sm text-slate-600 dark:text-zinc-500 mb-6 max-w-xs">The creatine encyclopedia. 100 entries cited from peer-reviewed sources.</p>
          <a href="#newsletter" class="inline-block px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors">New Entries</a>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Research</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science</a></li>
            <li><a href="/dosing" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing</a></li>
            <li><a href="/safety" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Applications</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/sports" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">By Sport</a></li>
            <li><a href="/comparisons" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Comparisons</a></li>
            <li><a href="/quality" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Product Quality</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Guides</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science/creatine-mechanisms-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science Guide</a></li>
            <li><a href="/dosing/creatine-dosing-protocols-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing Guide</a></li>
            <li><a href="/safety/creatine-safety-complete-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety Guide</a></li>
            <li><a href="/quality/creatine-buying-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Buying Guide</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Site</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Home</a></li>
            <li><a href="/articles" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">All Articles</a></li>
            <li><a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Scale With Search</a></li>
          </ul>
        </div>
      </div>
      <div class="pt-8 border-t border-slate-200 dark:border-zinc-900 flex flex-col md:flex-row items-center justify-between gap-4">
        <p class="text-xs text-slate-500 dark:text-zinc-700">&copy; 2026 Creatinepedia. All cited sources are property of their respective authors.</p>
        <p class="text-xs text-slate-500 dark:text-zinc-700">Powered by <a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-sky-500">Scale With Search</a></p>
      </div>
    </div>
  </footer>


  <script>
    // Theme
    if (localStorage.theme === 'light') {
      document.documentElement.classList.remove('dark');
    } else if (localStorage.theme === 'dark' || !('theme' in localStorage)) {
      document.documentElement.classList.add('dark');
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
      document.documentElement.classList.add('dark');
    }

    // Mega menu
    (function() {
      const triggers = document.querySelectorAll('.mega-trigger');
      const panels = document.querySelectorAll('.mega-panel');
      let activePanel = null;
      let closeTimeout = null;

      function openPanel(id) {
        clearTimeout(closeTimeout);
        panels.forEach(p => { p.classList.add('hidden'); });
        triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        const panel = document.getElementById('mega-' + id);
        const trigger = document.querySelector('[data-mega="' + id + '"] .mega-trigger');
        if (panel) { panel.classList.remove('hidden'); activePanel = panel; }
        if (trigger) trigger.setAttribute('aria-expanded', 'true');
      }

      function scheduleClose() {
        closeTimeout = setTimeout(() => {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
          activePanel = null;
        }, 200);
      }

      function cancelClose() { clearTimeout(closeTimeout); }

      triggers.forEach(btn => {
        const wrapper = btn.closest('[data-mega]');
        const id = wrapper.getAttribute('data-mega');
        btn.addEventListener('mouseenter', () => openPanel(id));
        btn.addEventListener('click', (e) => {
          e.preventDefault();
          const panel = document.getElementById('mega-' + id);
          if (panel && !panel.classList.contains('hidden')) {
            panel.classList.add('hidden');
            btn.setAttribute('aria-expanded', 'false');
          } else {
            openPanel(id);
          }
        });
        wrapper.addEventListener('mouseleave', scheduleClose);
      });

      panels.forEach(panel => {
        panel.addEventListener('mouseenter', cancelClose);
        panel.addEventListener('mouseleave', scheduleClose);
      });

      document.addEventListener('click', (e) => {
        if (!e.target.closest('[data-mega]') && !e.target.closest('.mega-panel')) {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });

      document.addEventListener('keydown', (e) => {
        if (e.key === 'Escape') {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });
    })();

    // Mobile menu
    const mobileMenuBtn = document.getElementById('mobile-menu-btn');
    const mobileMenu = document.getElementById('mobile-menu');
    const menuIcon = document.getElementById('menu-icon');
    const closeIcon = document.getElementById('close-icon');
    if (mobileMenuBtn) {
      mobileMenuBtn.addEventListener('click', () => {
        mobileMenu.classList.toggle('hidden');
        menuIcon.classList.toggle('hidden');
        closeIcon.classList.toggle('hidden');
      });
    }

    // Mobile accordion sections
    document.querySelectorAll('.mobile-section-toggle').forEach(btn => {
      btn.addEventListener('click', () => {
        const section = btn.nextElementSibling;
        const chevron = btn.querySelector('svg');
        section.classList.toggle('hidden');
        chevron.style.transform = section.classList.contains('hidden') ? '' : 'rotate(180deg)';
      });
    });
  </script>
</body>
</html>